RCM
SRDX

Rotella Capital Management’s Surmodics SRDX Stock Holding History

Rotella Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-27,407
Closed -$556K – 210
2015
Q4 		$556K Sell
27,407
-36,116
-57% -$767K 0.5% 11
2015
Q3 		$1.39M Buy
+63,523
New +$1.49M 0.45% 28

Other funds holding SRDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Rotella Capital Management's SRDX Position: Q1 2016 in Review

Rotella Capital Management sold out of Surmodics (SRDX) in Q1 2016, closing a stake of 27,407 shares — an estimated $556K sold.

Rotella Capital Management first reported a position in SRDX in Q3 2015 and held it in 2 quarters. The position peaked at $1.39M in Q3 2015. 118 funds tracked by Wall St. Rank hold SRDX as of Q1 2016.

  • Rotella Capital Management reported no remaining Surmodics position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 27,407 Surmodics shares in Q1 2016, an estimated $556K.
  • Rotella Capital Management first reported a position in Surmodics in Q3 2015 and held it in 2 quarters.
  • Rotella Capital Management's Surmodics position peaked at $1.39M in Q3 2015.
  • 118 funds tracked by Wall St. Rank held Surmodics as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.